Navigation Links
5th Annual Summit to Feature New Stem Cell Therapies
Date:1/8/2010

WAYNE, Pa., Jan. 8 /PRNewswire/ -- Six new stem cell therapies, all forecast to reach physicians in 2010, will be featured at the 5th Annual Stem Cell Summit on February 16 in New York City. These new therapies include allograft products, innovative forms of autologous stem cell technologies, and at least one FDA-approved stem cell drug. New studies showing rehydration of the disc nucleus, regeneration of new heart muscle and others are also on the agenda.

The Stem Cell Summit is an annual gathering of stem cell and biomaterial company executives, scientists and investors to explore the therapeutic applications of stem cells, the successful path to stem cell product commercialization, and the latest investment opportunities within the space. The Summit features 35 corporate presentations, a scientific panel, separate tracks for stem cell tools & instruments, and a closing reception. It is an intensive one-day event held at Bridgewaters in New York City's historic South Street Seaport.


                  The presenting stem cell companies include:

    Aastrom Biosciences, Inc.     INCELL Corporation, LLC
    AllCells, LLC                 International Stem Cell Corp.
    AlloSource                    Lonza Group Ltd.
    Aldagen, Inc.                 MaxCyte, Inc.
    ArunA Biomedical, Inc.        Mesoblast Limited
    Athersys, Inc.                Novocell, Inc.
    BioE Inc.                     Osiris Therapeutics, Inc.
    Cardiogenesis Corp.           Pluristem Therapeutics Inc.
    Cellerix, S.A.                ProChon Biotech, Ltd.
    Celtigen Therapeutics, LLC    Progenitor Cell Therapy, Inc.
    Core Dynamics Ltd.            SpineSmith Partners LP
    Cytori Therapeutics, Inc.     Stematix, Inc.
    Gamida Cell Ltd.              Stemina Biomarker Discovery, Inc.
    Garnet BioTherapeutics, Inc.  TiGenix NV
    Genzyme Biosurgery            Tissue Genesis, Inc.
    Glycosan BioSystems, Inc.     TxCell SA
    Harvest Technologies Corp.    Vet-Stem, Inc.
    Histogen, Inc.

In addition to the company and scientific presentations, Robin R. Young, CFA, a leading medical technologies analyst, will deliver his updated 10-year market forecast for the industry. "In 2009, the number of new market entrants was notable, but there were some difficulties with regard to clinical trials. Nevertheless, sales of stem cell therapies continue to grow extremely rapidly in the United States. We now estimate that revenues from stem cell therapies will surpass $2.5 billion by 2015 and that the industry will support a $10 billion valuation," said Young.


                 5th Annual Stem Cell Summit Facts at a Glance

    When:            Tuesday, February 16, 2010

    Where:           Bridgewaters
                     11 Fulton Street
                     New York City

    Admission:       $1,200 advance registration by January 31, 2010
                     $1,500 (February 1 - 16, 2010)

    Information:     A detailed agenda and online registration are
                     available at www.stemcellsummit.com.


    Contact:          Lisa Carpenter
                      RRY Publications, LLC
                      877-817-6450
                      lisa@ryortho.com


SOURCE Stem Cell Summit

RELATED LINKS
http://www.stemcellsummit.com

'/>"/>

SOURCE Stem Cell Summit
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
2. Sinovac Announces Postponement of Annual General Meeting
3. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
6. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
7. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
8. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
9. Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference
10. Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
11. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... NY (PRWEB) , ... January 20, 2017 , ... Nipro ... a Joint Venture (JV) under which Nipro will receive exclusive marketing and sales rights ... to establish best practices for hemodialysis patients in Japan, the new Nipro - Transonic ...
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... Kan. , Jan. 20, 2017 Aratana ... therapeutics company focused on the licensing, development and commercialization ... Animal Pharm,s Best Company in North ... granted the award based on the FDA ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) ...
(Date:1/20/2017)... ... 2017 , ... The two newest companies to join the University City Science ... out from The Wistar Institute, and Sanguis, launched by a trio of students from ... , Vironika is developing a treatment for a chronic viral infection and its associated ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... --  IdentyTechSolutions America LLC , a leading provider ... a cutting-edge manufacturer of software and hardware security ... integrated solutions that comprise IDT biometric readers and ... IdentyTech,s customers with combined physical identification and anti-tailgating ... theft. "We are proud to use ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
Breaking Biology News(10 mins):